Tumorigenesis is viewed as a multistep process with sequential acquisition of genetic lesions including gene ampli®cation, mutations and deletions leading to the pleiotropic phenotypes of cancer cells (Bishop, 1991; Hanahan and Weinberg, 2000) . A key event in the transformation process of many tumors is the constitutive activation of genes of the ras family through gain-of-function mutations (Bos, 1989) . Ras genes encode GTP/GDP binding proteins and are major switches of signaling pathways by coupling extracellular stimuli with the activation of transcription factors (Barbacid, 1987; Campbell et al., 1998; Malumbres and Pellicier, 1998) . Mutations stabilize ras in its active state and as a result constitutive signaling together with other cooperating alterations leads to malignant transformation (Barbacid, 1987; Land et al., 1983; Klein, 1987) . In addition, it has been shown that ras induces genomic instability in murine ®broblasts in vitro within one cell cycle which would further accelerate the malignant process (Denko et al., 1994) .
With respect to the genetic basis of oncogenesis, two numbers are of relevance. The ®rst is the minimal number of genetic changes occurring accidentally or in response to carcinogenic insults. This ®gure can be estimated from natural tumors by molecular analysis and by statistical-epidemiological studies and has been predicted in carcinomas to be smaller than 10 (Ashley, 1969) . The second measure is the total number of genes whose expression is aected downstream of the primary, carcinogenic lesion. This number is more dicult to assess, and has, in the past, been estimated from 2D-analysis of protein comparisons between normal and malignant cells, or at the transcriptional level by dierential mRNA display (Sager et al., 1993; Buess et al., 1999) . The more recent development of DNA microarray technologies allows the multiparallel analysis of several thousand of transcripts in a single experiment. This technology is well suited to analyse dierential gene expression in several independent tumors derived from the same precursor cell. Based on the number of dierentially expressed genes it is possible to estimate the total number of genes involved in tumorigenesis. In v-H-ras transformed rat embryo ®broblasts, for instance, the expression of about 400 genes was altered after transformation based on subtractive mRNA hybridization data (Zuber et al., 2000) .
Using DNA oligonucleotide arrays we determine here the number of dierentially expressed genes in an experimental model , in which establishment of an autocrine IL-3 loop is the hallmark of tumor lines generated from IL-3 dependent mast cells. PB-3c and two of its subclones (clone 15 and clone 56) are normal, IL-3 dependent mast cells, which were transfected with the v-H-ras oncogene, giving rise to cells with a decreased IL-3 dependency. In vivo progression of these cells in mice leads to an IL-3 producing autocrine tumor phenotype ( Figure 1a) . The stable expression of IL-3 in these tumors (Figure 1b) is the result of two dierent mechanisms: Class I tumors (V2D1, 15V4T21) show a defect in IL-3 mRNA turnover leading to enhanced mRNA stability. Autocrine expression in this tumor class appears to occur in trans as it can be downregulated by somatic cell fusion with PB-3c . Class II tumors carry an insertion of an intracisternal A-Particle in the IL-3 promoter region leading to stable upregulation of IL-3 transcription. Contrary to class I tumors IL-3 expression is dominant in this subtype and cannot be altered by somatic cell fusion (Hirsch et al., 1993) . Gene expression was monitored with commercial DNA oligonucleotide arrays with probe sets for about 11 000 known genes and EST's. Each gene is represented by a set of 40 oligonucleotides with an average length of 20 bases. Half of these correspond to the sequence of the mRNA and the other half has a mismatch in the center position to control speci®city of hybridization. Twenty mg of total RNA was transcribed into cDNA followed by linear in vitro transcription (IVT) as described by the supplier of the microarrays (Aymetrix Inc., Santa Clara, CA, USA). Fifteen mg ampli®ed cRNA per array were hybridized overnight at 458C (Mu11KsubA array and Mu11KsubB, Aymetrix Inc., Santa Clara, CA, USA) with some modi®cations (Certa et al., 2000) . After hybridization, washing and staining, the arrays were scanned with a confocal laser scanner. Raw data were generated using GeneChip3.0 software (Aymetrix, Inc., Santa Clara, CA, USA). Two independent cell cultures of the progenitor and the tumor lines were analysed and the data were electronically merged into a single data set. Transcript levels were expressed as the average dierence of hybridization signals, measured as¯uores-cence intensity, between perfect match and central mismatch oligonucleotide probe sets. Data from dierent chips were normalized using the total chip signal as a basis to calculate the normalization factor. A threshold of 20 arbitrary¯uorescence units was assigned to any gene with a calculated expression level below 20, since discrimination of mRNA levels in this low range cannot be performed with high con®dence. Fold changes of expression were only considered when at least three-fold over PB3c and a change factor quality value of 51 (meaning that the sum of the two standard deviations is smaller than the dierence between the two mean average dierence values) Figure 1 Outline of the mouse mastocyte tumor model system. (a) Generation of the tumor lines by v-H-ras transformation. PB3c is a cloned, IL-3 dependent mast cell line, and cl56 and cl15 are subclones. Following v-H-ras transformation, progenitor cells (R56, V2, 15V4) remained IL-3 dependent and became autocrine once they progressed in vivo to tumors (R56VT, V2D1, 15V4T21; for details see Hirsch et al., 1993) . (b) Transcript levels of IL-3 assayed by RT ± PCR. Total RNA was isolated with RNAzol B (TEL-TEST, Friendswood, TX, USA) according to the manufacturer's instructions. 2.5 mg of total RNA was denatured and cDNA was synthesized using the superscript choice system from Gibco ± BRL (Gaithersburg, MD, USA) using an IL-3 speci®c upstream primer (5'-TCCACAAGGGACAAATGAAC-3'). Subsequent PCR ampli®cation was performed in a reaction volume of 100 ml, using 20 pmoles of primers and 5 U Taq Polymerase (Roche Diagnostics) in 10 mM Tris, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.2 mM dNTP. IL-3 mRNA was ampli®ed in 40 cycles (968C for 1 min, 608C for 2 min and 728C for 2 min). The downstream primer had the sequence 5'-GGATCCTGAGGACA-GATACG-3'. After ampli®cation an aliquot of each reaction was analysed by gel electrophoresis on a 1% agarose gel From three IL-3 autocrine tumor lines and the parental cell line PB-3c¯uorescently labeled cRNA was prepared and hybridized to oligonucleotide arrays. Integrity of the RNA samples was con®rmed by RT ± PCR ampli®cation of IL-3 mRNA (Figure 1b) , and in a Northern blot experiment con®rming dierential expression of 1 ± 8 days (data not shown). In addition, the microarray technology itself provides built-in quality control features which control cRNA sample integrity by measuring the expression level of the 5', middle and 3' region of three housekeeping genes (glycerolaldehyde-3-phosphate dehydrogenase, bactin and hexokinase). The commercial arrays used contain oligonucleotide probes capable to analyse about 11 000 mouse genes. The available gene panel contains all mouse genes known in the year 1998 and in addition probe sets for about 3000 expressed sequence tags (EST's). In all lines including the precursor line PB-3c about 32% of the genes detectable on the chip were scored as being expressed (data not shown). This indicates that the overall transcriptional activity of the mouse genome is not altered signi®cantly by ras transformation and tumor formation in the mouse. In the data analysis we included only genes which gave reproducible hybridization signals and signi®cant change factors in two independent experiments. For instance, we chose only those genes whose expression level changed at least threefold with a change quality factor of 41, meaning that the sum of the two standard deviations of the average dierences in two experiments is smaller than the dierence between the two mean average dierence values. Under these stringent analysis conditions, the transcriptional activity of about 400 ± 600 genes was found to be modulated in the tumor lines compared to the PB-3c precursor cell. Interestingly, this ®gure is in the same order of magnitude as in ras transformed rat ®broblasts (Figure 2 ; Zuber et al., 2000) . However, only 75 genes are dierentially expressed in all three tumor clones (Figure 3 ) and the remainder diers between the lines probably as a result of clonal variation. It may thus be inaccurate to assign tumor phenotypes based on a single marker such as IL-3. Furthermore it is noteworthy, that the direction of the change is uniform for 70 out of 75 genes in all three tumor lines relative to the precursor cell. The ®ve genes violating the rule appear all in the class II tumor line R56VT, suggesting perhaps a speci®c oncogenic pathway. However, the current knowledge about the function of these genes is limited and shows no obvious link to IL-3 transcription.
Forty genes modulated in all tumor lines belong to classes functionally related to the process of oncogenesis such as signaling molecules, proteolytic systems, transcription factors or adhesion proteins whereas 35 genes have no obvious relation to tumor biology or represent uncharacterized EST's (Figure 3 ). Established marker genes of normal mast cells such as the high anity IgE receptor (FcER1), 114/A10, M290 integrin or tryptophan hydroxylase were all found to be downregulated in tumor cells, re¯ecting their less dierentiated state (Ra et al., 1989; Smith et al., 1994; Ziegler et al., 1993; Dougherty et al., 1989) . Four genes (mast cell protease 2, fructose 1,6-biphosphatase, intracisternal A particle and calcium channel mtrp 6) have previously been detected by dierential display PCR in the same tumor system (Buess et al., 1999) .
Several protease or apoptosis genes are dierentially expressed in the tumor lines. Unexpected was the downregulation of the oncogene Bcl-2 in the tumors, although a dual function for this polypeptide as an inhibitor of apoptosis and stimulator of cell proliferation has been reported (Puthier et al., 1999) . It is interesting to note, that Mtd, a family member of Bcl-2 was upregulated (Inohara et al., 1998) . The induction of cathepsin expression is also believed to be involved in tumor progression (Yan et al., 1998) . Another protease, calpain 2, has been reported to degrade the tumor suppressor protein p53 in vitro, which would promote malignant growth (Pariat et al., 1997) . Downregulation of the rsu-1 gene, whose product suppresses ras mediated transformation in NIH3T3 cells, may be essential for v-H-ras mediated transformation in our tumor model (Cutler et al., 1992) . Interestingly, another putative tumor suppressor gene (AA170698) identi®ed by sequence homology, is also downregulated.
Intriguing is the observation that four interferon inducible genes are strongly repressed in all tumor lines. This is consistent with the known antiproliferative eect of interferons and it is possible that interferon therapy activates these genes and restores normal cell proliferation. Interestingly, one of them, the human 9-27 gene product Leu-13 has been indirectly associated with cell proliferation based on experiments with inhibitory monoclonal antibodies (Deblandre et al., 1995) . Surprising was also the upregulation of placental lactogen, a protein closely related to growth hormone, in all three tumors. In transgenic mice, mPL-1 increases the proliferation of beta cells two fold and up to now the protein was not found to be associated with tumorigenesis (Vasavada et al., 2000) . a-fetoprotein and Id2, a helix ± loop ± helix protein were previously associated with either spontaneous liver-cell cancer or pancreatic cancer respectively (Jalanko et al., 1978; Klee et al., 1998) . The upregulation of both genes in this model possibly points to a more general role of them in oncogenesis. The function of the unknown genes (EST's) may be of equal importance for oncogenesis because they are part of the gene pool dierentially expressed in all tumor lines.
Lastly, the current study permits a conservative estimate of the total number of genes involved in tumor formation. The microarrays used here are able to detect transcripts of around 11 000 genes which corresponds based on current estimates to about 15% of the mouse genome (80 000 genes). Seventy-®ve (0.68%) are dierentially expressed in all three tumor lines and it is plausible to assume that their function is important for v-H-ras mediated tumorigenesis in this model. Thus, the activity of close to 500 genes might be essential and required for the process of malignant transformation. If the tumor line speci®c genes are included in the calculation this number raises to about 2000 which corresponds approximately to the number of dierentially expressed genes found in ras transformed rat ®broblasts by dierential display (Zuber et al., 2000) .
Our data are consistent with a model in which progressive genetic instability occurs in tumor cells together with chromosome rearrangements, mutations and deletions resulting in clone speci®c expression patterns. The genes contained in the tumor line-speci®c gene set may re¯ect clonal variation whereas the shared genes are likely candidates essential for ras-triggered tumor formation. This core group of genes might not only contain useful markers for clinical diagnosis of malignancy, but may provide also novel targets for tumor therapy. Additional candidates should emerge when whole genome DNA microarrays become available.
